Skip to main content
Premium Trial:

Request an Annual Quote

Expression Analysis Renews Microarray Service Contract with Duke

NEW YORK, June 3 (GenomeWeb News) - Expression Analysis has renewed and extended a 2001 Affymetrix microarray service agreement with Duke University Medical Center, the company said yesterday.


Expression Analysis, based in Durham, NC, will continue to provide microarray analysis services to Duke for at least three and up to five years, using the Affymetrix platform.


The company said it will soon expand its services to include RNA isolation from paraffin-embedded tissue and genotyping.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.